239 related articles for article (PubMed ID: 29715450)
1. RACking up ceramide-induced islet β-cell dysfunction.
Kowluru A; Kowluru RA
Biochem Pharmacol; 2018 Aug; 154():161-169. PubMed ID: 29715450
[TBL] [Abstract][Full Text] [Related]
2. Potential roles of PP2A-Rac1 signaling axis in pancreatic β-cell dysfunction under metabolic stress: Progress and promise.
Kowluru A
Biochem Pharmacol; 2020 Oct; 180():114138. PubMed ID: 32634437
[TBL] [Abstract][Full Text] [Related]
3. Glucotoxicity promotes aberrant activation and mislocalization of Ras-related C3 botulinum toxin substrate 1 [Rac1] and metabolic dysfunction in pancreatic islet β-cells: reversal of such metabolic defects by metformin.
Baidwan S; Chekuri A; Hynds DL; Kowluru A
Apoptosis; 2017 Nov; 22(11):1380-1393. PubMed ID: 28828705
[TBL] [Abstract][Full Text] [Related]
4. Phagocyte-like NADPH oxidase (Nox2) promotes activation of p38MAPK in pancreatic β-cells under glucotoxic conditions: Evidence for a requisite role of Ras-related C3 botulinum toxin substrate 1 (Rac1).
Sidarala V; Veluthakal R; Syeda K; Vlaar C; Newsholme P; Kowluru A
Biochem Pharmacol; 2015 Jun; 95(4):301-10. PubMed ID: 25881746
[TBL] [Abstract][Full Text] [Related]
5. Regulatory roles of CARD9-BCL10-Rac1 (CBR) signalome in islet β-cell function in health and metabolic stress: Is there room for MALT1?
Kowluru A
Biochem Pharmacol; 2023 Dec; 218():115889. PubMed ID: 37991197
[TBL] [Abstract][Full Text] [Related]
6. RhoG-Rac1 Signaling Pathway Mediates Metabolic Dysfunction of the Pancreatic Beta-Cells Under Chronic Hyperglycemic Conditions.
Chundru SA; Harajli A; Hali M; Gleason N; Gamage S; Kowluru A
Cell Physiol Biochem; 2021 Apr; 55(2):180-192. PubMed ID: 33851799
[TBL] [Abstract][Full Text] [Related]
7. Roles of GTP and Rho GTPases in pancreatic islet beta cell function and dysfunction.
Kowluru A
Small GTPases; 2021; 12(5-6):323-335. PubMed ID: 32867592
[TBL] [Abstract][Full Text] [Related]
8. Tiam1/Rac1 signaling pathway mediates palmitate-induced, ceramide-sensitive generation of superoxides and lipid peroxides and the loss of mitochondrial membrane potential in pancreatic beta-cells.
Syed I; Jayaram B; Subasinghe W; Kowluru A
Biochem Pharmacol; 2010 Sep; 80(6):874-83. PubMed ID: 20493824
[TBL] [Abstract][Full Text] [Related]
9. Small G proteins in islet beta-cell function.
Kowluru A
Endocr Rev; 2010 Feb; 31(1):52-78. PubMed ID: 19890090
[TBL] [Abstract][Full Text] [Related]
10. Friendly, and not so friendly, roles of Rac1 in islet β-cell function: lessons learnt from pharmacological and molecular biological approaches.
Kowluru A
Biochem Pharmacol; 2011 Apr; 81(8):965-75. PubMed ID: 21300027
[TBL] [Abstract][Full Text] [Related]
11. L- threo -C6-pyridinium-ceramide bromide, a novel cationic ceramide, induces NADPH oxidase activation, mitochondrial dysfunction and loss in cell viability in INS 832/13 β-cells.
Syed I; Szulc ZM; Ogretmen B; Kowluru A
Cell Physiol Biochem; 2012; 30(4):1051-8. PubMed ID: 23052231
[TBL] [Abstract][Full Text] [Related]
12. Role of G-proteins in islet function in health and diabetes.
Kowluru A
Diabetes Obes Metab; 2017 Sep; 19 Suppl 1(Suppl 1):63-75. PubMed ID: 28880478
[TBL] [Abstract][Full Text] [Related]
13. The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond.
Moon JS; Karunakaran U; Suma E; Chung SM; Won KC
Diabetes Metab J; 2020 Apr; 44(2):222-233. PubMed ID: 32347024
[TBL] [Abstract][Full Text] [Related]
14. Exposure to chronic hyperglycemic conditions results in Ras-related C3 botulinum toxin substrate 1 (Rac1)-mediated activation of p53 and ATM kinase in pancreatic β-cells.
Sidarala V; Kowluru A
Apoptosis; 2017 May; 22(5):597-607. PubMed ID: 28220272
[TBL] [Abstract][Full Text] [Related]
15. Tiam1/Vav2-Rac1 axis: A tug-of-war between islet function and dysfunction.
Kowluru A
Biochem Pharmacol; 2017 May; 132():9-17. PubMed ID: 28202288
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomics reveals novel interaction partners of Rac1 in pancreatic β-cells: Evidence for increased interaction with Rac1 under hyperglycemic conditions.
Damacharla D; Thamilselvan V; Zhang X; Mestareehi A; Yi Z; Kowluru A
Mol Cell Endocrinol; 2019 Aug; 494():110489. PubMed ID: 31202817
[TBL] [Abstract][Full Text] [Related]
17. Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes.
Lytrivi M; Castell AL; Poitout V; Cnop M
J Mol Biol; 2020 Mar; 432(5):1514-1534. PubMed ID: 31628942
[TBL] [Abstract][Full Text] [Related]
18. The two faces of protein palmitoylation in islet β-cell function: potential implications in the pathophysiology of islet metabolic dysregulation and diabetes.
Mohammed AM; Chen F; Kowluru A
Recent Pat Endocr Metab Immune Drug Discov; 2013 Sep; 7(3):203-12. PubMed ID: 23829395
[TBL] [Abstract][Full Text] [Related]
19. Role of ceramide in diabetes mellitus: evidence and mechanisms.
Galadari S; Rahman A; Pallichankandy S; Galadari A; Thayyullathil F
Lipids Health Dis; 2013 Jul; 12():98. PubMed ID: 23835113
[TBL] [Abstract][Full Text] [Related]
20. A lack of 'glue' misplaces Rab27A to cause islet dysfunction in diabetes.
Kowluru A
J Pathol; 2016 Feb; 238(3):375-7. PubMed ID: 26575346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
